HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Florian Kahles Selected Research

Aftercare (After-Treatment)

1/2017The PDE4 inhibitor roflumilast reduces weight gain by increasing energy expenditure and leads to improved glucose metabolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Florian Kahles Research Topics

Disease

12Inflammation (Inflammations)
03/2024 - 12/2013
7Atherosclerosis
01/2021 - 12/2013
5Myocardial Infarction
01/2024 - 12/2018
5Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2018
3Chronic Obstructive Pulmonary Disease (COPD)
03/2024 - 01/2017
3Hypertension (High Blood Pressure)
12/2020 - 01/2019
3Critical Illness (Critically Ill)
01/2017 - 10/2014
2Fibrosis (Cirrhosis)
03/2024 - 11/2022
2Body Weight (Weight, Body)
03/2024 - 01/2017
2Sepsis (Septicemia)
01/2024 - 01/2017
2Heart Failure
10/2023 - 12/2020
2Atherosclerotic Plaque (Atheroma)
01/2021 - 01/2018
2Obesity
01/2019 - 07/2014
2Insulin Resistance
01/2017 - 07/2014
1Dyspnea (Shortness of Breath)
05/2024
1Muscle Weakness
05/2024
1Hypercapnia
03/2024
1Liver Diseases (Liver Disease)
03/2024
1Hyperlipidemias (Hyperlipidemia)
03/2024
1Glucose Intolerance
03/2024
1Cardiogenic Shock
01/2024
1Shock
01/2024
1Cardiomegaly (Heart Hypertrophy)
11/2022
1Vascular Calcification
01/2022
1Human Influenza (Influenza)
01/2022
1Systolic Heart Failure
01/2022
1Infections
01/2022
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Disorders of Excessive Somnolence (Hypersomnia)
01/2021
1ST Elevation Myocardial Infarction
01/2020
1Non-ST Elevated Myocardial Infarction
01/2020
1Sleep Deprivation
01/2019
1Myocarditis (Carditis)
01/2019
1Amyloidosis
11/2017
1Cardiomyopathies (Cardiomyopathy)
11/2017
1Heart Diseases (Heart Disease)
11/2017
1Alcoholic Fatty Liver
01/2017
1Fatty Liver
01/2017
1Kidney Diseases (Kidney Disease)
01/2017
1Chronic Kidney Failure (Chronic Renal Failure)
01/2017
1Weight Gain
01/2017
1Weight Loss (Weight Reduction)
01/2017
1Chronic Renal Insufficiency
01/2017
1Neointima
04/2015
1Vascular Diseases (Vascular Disease)
04/2015

Drug/Important Bio-Agent (IBA)

9Glucagon-Like Peptide 1 (GLP 1)IBA
01/2024 - 12/2013
8Glucose (Dextrose)FDA LinkGeneric
03/2024 - 10/2014
3Biomarkers (Surrogate Marker)IBA
01/2024 - 12/2020
2Amyloid (Amyloid Fibrils)IBA
01/2021 - 11/2017
2pro-brain natriuretic peptide (1-76)IBA
01/2021 - 01/2020
2Apolipoproteins E (ApoE)IBA
01/2021 - 01/2018
2Interleukin-3 (Interleukin 3)IBA
01/2021 - 01/2019
2C-Reactive ProteinIBA
12/2020 - 01/2020
2Glucagon-Like Peptide-1 ReceptorIBA
01/2019 - 10/2014
2IncretinsIBA
01/2019 - 01/2018
2RoflumilastIBA
01/2017 - 04/2015
2Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
01/2017 - 04/2015
2OsteopontinIBA
12/2016 - 07/2014
1salicylhydroxamic acid (SHAM)IBA
05/2024
1Adrenergic Agents (Adrenergic Drugs)IBA
03/2024
1(1-3)(1-4)- beta-glucanIBA
03/2024
1Therapeutic UsesIBA
03/2024
1Polysaccharides (Glycans)IBA
03/2024
1beta-GlucansIBA
03/2024
1Proteins (Proteins, Gene)FDA Link
11/2022
1SodiumIBA
11/2022
1Sirolimus (Rapamycin)FDA Link
11/2022
1SymportersIBA
11/2022
1Sodium-Glucose Transporter 2 InhibitorsIBA
11/2022
1ertugliflozinIBA
11/2022
1NicotineFDA Link
01/2022
1Corticotropin-Releasing HormoneIBA
01/2022
1Peptides (Polypeptides)IBA
01/2021
1Calcium-Sensing ReceptorsIBA
01/2021
1CholesterolIBA
01/2021
1Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA
12/2020
1Peptide YYIBA
12/2020
1Troponin T (Troponin T1)IBA
01/2020
1Brain Natriuretic Peptide (Natrecor)FDA Link
01/2020
1NeuropeptidesIBA
01/2019
1OrexinsIBA
01/2019
1ChemokinesIBA
01/2019
1Orexin ReceptorsIBA
01/2019
1IntegrinsIBA
01/2019
1SugarsIBA
01/2019
1CollagenIBA
01/2018
1Hormones (Hormone)IBA
01/2018
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
01/2018
1Prealbumin (Transthyretin)IBA
11/2017
1Phosphodiesterase 4 InhibitorsIBA
01/2017
1Annexin A5IBA
01/2017
1Interleukin-6 (Interleukin 6)IBA
02/2016
1Histones (Histone)IBA
04/2015

Therapy/Procedure

3Therapeutics
10/2023 - 12/2013
1Noninvasive Ventilation
03/2024
1Microelectrodes
01/2022
1Ligation
12/2018
1Aftercare (After-Treatment)
01/2017
1Renal Dialysis (Hemodialysis)
01/2017
1Stents
04/2015